- Home
- MLGO vs BIOA Comparison
MLGO vs BIOA Comparison
Compare MLGO & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- BIOA
- Stock Information
- Founded
- MLGO 2018
- BIOA 2015
- Country
- MLGO China
- BIOA United States
- Employees
- MLGO N/A
- BIOA N/A
- Industry
- MLGO EDP Services
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- BIOA Health Care
- Exchange
- MLGO Nasdaq
- BIOA Nasdaq
- Market Cap
- MLGO 139.5M
- BIOA 139.1M
- IPO Year
- MLGO N/A
- BIOA 2024
- Fundamental
- Price
- MLGO $18.45
- BIOA $3.40
- Analyst Decision
- MLGO
- BIOA Hold
- Analyst Count
- MLGO 0
- BIOA 4
- Target Price
- MLGO N/A
- BIOA $5.67
- AVG Volume (30 Days)
- MLGO 33.1M
- BIOA 189.1K
- Earning Date
- MLGO 04-15-2025
- BIOA 05-15-2025
- Dividend Yield
- MLGO N/A
- BIOA N/A
- EPS Growth
- MLGO N/A
- BIOA N/A
- EPS
- MLGO N/A
- BIOA N/A
- Revenue
- MLGO $83,504,125.00
- BIOA N/A
- Revenue This Year
- MLGO N/A
- BIOA N/A
- Revenue Next Year
- MLGO N/A
- BIOA N/A
- P/E Ratio
- MLGO N/A
- BIOA N/A
- Revenue Growth
- MLGO 643.57
- BIOA N/A
- 52 Week Low
- MLGO $1.11
- BIOA $3.34
- 52 Week High
- MLGO $509.60
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- MLGO 67.03
- BIOA N/A
- Support Level
- MLGO $17.22
- BIOA N/A
- Resistance Level
- MLGO $32.40
- BIOA N/A
- Average True Range (ATR)
- MLGO 5.65
- BIOA 0.00
- MACD
- MLGO 1.25
- BIOA 0.00
- Stochastic Oscillator
- MLGO 54.01
- BIOA 0.00
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.